DMAC — DIAMEDICA THERAPEUTICS INC

Ownership history in COOPERMAN LEON G  ·  16 quarters on record

This page tracks every 13F SEC filing in which COOPERMAN LEON G reported a position in DIAMEDICA THERAPEUTICS INC (DMAC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.55% (2025 Q3)
Avg. % of fund
0.18%
First filed
2020 Q4
Last filed
2025 Q4
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 2,020,000 -1,249,761 -38.2% 0.53% $16.1M $7.96
2025 Q3 ADDED 3,269,761 +1,619,761 +98.2% 0.55% $17.6M $6.87
2025 Q2 ADDED 1,650,000 +25,000 +1.5% 0.23% $6.4M $3.90
2025 Q1 UNCHANGED 1,625,000 — 0% 0.25% $6.2M $3.79
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DMAC price (monthly, adj. close)

Other funds also holding DMAC

As of 2025 Q4 — sorted by position size

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 3Y 7Y 14.39% Bleichroeder LP 3Y 0.54% MAGNOLIA CAPITAL ADVISORS LLC 3Y 0.13% Informed Momentum Co LLC 3Y 7Y 0.08% Private Capital Management, LLC 3Y 7Y 0.04% CATALYST FINANCIAL PARTNERS LLC 3Y 0.03% AXQ CAPITAL, LP 3Y 0.02% Truvestments Capital LLC 3Y 7Y 0.01% Meridian Wealth Management, LLC 3Y 7Y 0.01% Stonebridge Capital Advisors LLC 3Y 7Y 0.01%
← Back to COOPERMAN LEON G Holdings